The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030

B Vogel, M Acevedo, Y Appelman, CNB Merz… - The Lancet, 2021 - thelancet.com
Cardiovascular disease is the leading cause of death in women. Decades of grassroots
campaigns have helped to raise awareness about the impact of cardiovascular disease in …

Management of Patients With Severe Mitral Annular Calcification: JACC State-of-the-Art Review

O Chehab, R Roberts-Thomson, A Bivona, H Gill… - Journal of the American …, 2022 - jacc.org
Mitral annular calcification (MAC) is a common and challenging pathologic condition,
especially in the context of an aging society. Surgical mitral valve intervention in patients …

2-year outcomes of transcatheter mitral valve replacement in patients with annular calcification, rings, and bioprostheses

MF Eleid, DD Wang, A Pursnani, SK Kodali… - Journal of the American …, 2022 - jacc.org
Abstract Background The MITRAL (Mitral Implantation of Transcatheter Valves) trial is the
first prospective study for valve-in-mitral annular calcification (ViMAC), mitral valve-in-ring …

Valvular heart disease: from mechanisms to management

F Praz, F Beyersdorf, K Haugaa, B Prendergast - The Lancet, 2024 - thelancet.com
Valvular heart disease is common and its prevalence is rapidly increasing worldwide.
Effective medical therapies are insufficient and treatment was historically limited to the …

[HTML][HTML] Valvular heart disease: new concepts in pathophysiology and therapeutic approaches

MF Eleid, VT Nkomo, SV Pislaru… - Annual Review of …, 2023 - annualreviews.org
This review discusses recent advancements in the field of valvular heart disease. Topics
covered include recognition of the impact of atrial fibrillation on development and …

5-year prospective evaluation of mitral valve-in-valve, valve-in-ring, and valve-in-MAC outcomes: MITRAL trial final results

ME Guerrero, MF Eleid, DD Wang, A Pursnani… - Cardiovascular …, 2023 - jacc.org
Abstract Background The MITRAL (Mitral Implantation of Transcatheter Valves) trial is the
first prospective trial to evaluate the safety and feasibility of balloon-expandable aortic …

Mitral annular calcification and valvular dysfunction: multimodality imaging evaluation, grading, and management

B Xu, D Kocyigit, TKM Wang, CD Tan… - European Heart …, 2022 - academic.oup.com
Mitral annular calcification (MAC) refers to calcium deposition in the fibrous skeleton of the
mitral valve. It has many cardiovascular associations, including mitral valve dysfunction …

Emerging approaches to management of left ventricular outflow obstruction risk in transcatheter mitral valve replacement

MF Eleid, JD Collins, P Mahoney, EE Williamson… - Cardiovascular …, 2023 - jacc.org
An increasing number of patients with mitral valve disease are high risk for surgery and in
need of less invasive treatments including transcatheter mitral valve replacement (TMVR) …

1-Year outcomes following transfemoral transseptal transcatheter mitral valve replacement: the HighLife TSMVR feasibility study

LM Schneider, S Worthley, G Nickenig, Z Huczek… - Cardiovascular …, 2023 - jacc.org
Background A significant number of patients with severe mitral regurgitation (MR) are not
suitable for either surgical or transcatheter edge-to-edge repair because of high surgical risk …

[HTML][HTML] Imaging in transcatheter mitral valve replacement: state-of-art review

M Barreiro-Perez, B Caneiro-Queija, L Puga… - Journal of Clinical …, 2021 - mdpi.com
Mitral regurgitation is the second-most frequent valvular heart disease in Europe and it is
associated with high morbidity and mortality. Recognition of MR should encourage the …